The Valley Desk

NCT04963231 · Interventional trial

DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway

Overall registry status Completed

Phase 2

Conditions Genetic Obesity

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov